The global market for Manufacturing Execution Systems for Pharma and Biotech was valued at US$ 731 million in the year 2024 and is projected to reach a revised size of US$ 1271 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Manufacturing Execution Systems for Pharma and Biotech Market

Manufacturing Execution Systems for Pharma and Biotech is a specialized software solution that digitally manages, monitors, and documents the manufacturing lifecycle of pharmaceuticals within a GxP-regulated environment. It enforces standardized procedures (EBRs/MBRs), tracks material genealogy, and captures all process data and events in real-time from the shop floor. This ensures strict compliance with FDA 21 CFR Part 11 and other regulations, provides complete electronic batch records, and enables full traceability for lot lineage from raw materials to finished product, thereby guaranteeing product quality, data integrity, and accelerating batch release.

The industry's gross profit margin is around 60%.

North American market for Manufacturing Execution Systems for Pharma and Biotech is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Manufacturing Execution Systems for Pharma and Biotech is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Manufacturing Execution Systems for Pharma and Biotech in Large Enterprises is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Manufacturing Execution Systems for Pharma and Biotech include Lonza, Vimachem, Korber, MasterControl, POMS Corporation, AspenTech, GE Vernova, 凯睿德, Dassault Systemes, IBM, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Manufacturing Execution Systems for Pharma and Biotech, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Manufacturing Execution Systems for Pharma and Biotech.

The Manufacturing Execution Systems for Pharma and Biotech market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Manufacturing Execution Systems for Pharma and Biotech market comprehensively. Regional market sizes, concerning products by Type, by Application, by Class and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Manufacturing Execution Systems for Pharma and Biotech companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Manufacturing Execution Systems for Pharma and Biotech Market Report

Report Metric	Details
Report Name	Manufacturing Execution Systems for Pharma and Biotech Market
Accounted market size in year	US$ 731 million
Forecasted market size in 2031	US$ 1271 million
CAGR	8.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cloud-based On-premises
Segment by Class	Electronic Batch Records (EBR) Lot Genealogy and Traceability Equipment and Material Management Quality Management Integration Regulatory Compliance
Segment by Group	Direct Sales Distribution
Segment by Application	Large Enterprises SMEs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, Vimachem, Korber, MasterControl, POMS Corporation, AspenTech, GE Vernova, 凯睿德, Dassault Systemes, IBM, Rockwell Automation, ABB, Accevo Systems, AmpleLogic, Siemens Software, NNIT, Metronik, Tulip
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Class etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Manufacturing Execution Systems for Pharma and Biotech company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Manufacturing Execution Systems for Pharma and Biotech Market growing?

Ans: The Manufacturing Execution Systems for Pharma and Biotech Market witnessing a CAGR of 8.2% during the forecast period 2025-2031.

What is the Manufacturing Execution Systems for Pharma and Biotech Market size in 2031?

Ans: The Manufacturing Execution Systems for Pharma and Biotech Market size in 2031 will be US$ 1271 million.

Who are the main players in the Manufacturing Execution Systems for Pharma and Biotech Market report?

Ans: The main players in the Manufacturing Execution Systems for Pharma and Biotech Market are Lonza, Vimachem, Korber, MasterControl, POMS Corporation, AspenTech, GE Vernova, 凯睿德, Dassault Systemes, IBM, Rockwell Automation, ABB, Accevo Systems, AmpleLogic, Siemens Software, NNIT, Metronik, Tulip

What are the Application segmentation covered in the Manufacturing Execution Systems for Pharma and Biotech Market report?

Ans: The Applications covered in the Manufacturing Execution Systems for Pharma and Biotech Market report are Large Enterprises, SMEs

What are the Type segmentation covered in the Manufacturing Execution Systems for Pharma and Biotech Market report?

Ans: The Types covered in the Manufacturing Execution Systems for Pharma and Biotech Market report are Cloud-based, On-premises

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cloud-based

1.2.3 On-premises

1.3 Market by Class

1.3.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Class: 2020 VS 2024 VS 2031

1.3.2 Electronic Batch Records (EBR)

1.3.3 Lot Genealogy and Traceability

1.3.4 Equipment and Material Management

1.3.5 Quality Management Integration

1.3.6 Regulatory Compliance

1.4 Market by Group

1.4.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Group: 2020 VS 2024 VS 2031

1.4.2 Direct Sales

1.4.3 Distribution

1.5 Market by Application

1.5.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Large Enterprises

1.5.3 SMEs

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Perspective (2020-2031)

2.2 Global Manufacturing Execution Systems for Pharma and Biotech Growth Trends by Region

2.2.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Manufacturing Execution Systems for Pharma and Biotech Historic Market Size by Region (2020-2025)

2.2.3 Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Region (2026-2031)

2.3 Manufacturing Execution Systems for Pharma and Biotech Market Dynamics

2.3.1 Manufacturing Execution Systems for Pharma and Biotech Industry Trends

2.3.2 Manufacturing Execution Systems for Pharma and Biotech Market Drivers

2.3.3 Manufacturing Execution Systems for Pharma and Biotech Market Challenges

2.3.4 Manufacturing Execution Systems for Pharma and Biotech Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Manufacturing Execution Systems for Pharma and Biotech Players by Revenue

3.1.1 Global Top Manufacturing Execution Systems for Pharma and Biotech Players by Revenue (2020-2025)

3.1.2 Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Players (2020-2025)

3.2 Global Top Manufacturing Execution Systems for Pharma and Biotech Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Manufacturing Execution Systems for Pharma and Biotech Revenue

3.4 Global Manufacturing Execution Systems for Pharma and Biotech Market Concentration Ratio

3.4.1 Global Manufacturing Execution Systems for Pharma and Biotech Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Manufacturing Execution Systems for Pharma and Biotech Revenue in 2024

3.5 Global Key Players of Manufacturing Execution Systems for Pharma and Biotech Head office and Area Served

3.6 Global Key Players of Manufacturing Execution Systems for Pharma and Biotech, Product and Application

3.7 Global Key Players of Manufacturing Execution Systems for Pharma and Biotech, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Manufacturing Execution Systems for Pharma and Biotech Breakdown Data by Type

4.1 Global Manufacturing Execution Systems for Pharma and Biotech Historic Market Size by Type (2020-2025)

4.2 Global Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Type (2026-2031)

5 Manufacturing Execution Systems for Pharma and Biotech Breakdown Data by Application

5.1 Global Manufacturing Execution Systems for Pharma and Biotech Historic Market Size by Application (2020-2025)

5.2 Global Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Manufacturing Execution Systems for Pharma and Biotech Market Size (2020-2031)

6.2 North America Manufacturing Execution Systems for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025)

6.4 North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size (2020-2031)

7.2 Europe Manufacturing Execution Systems for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025)

7.4 Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size (2020-2031)

8.2 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2020-2025)

8.4 Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size (2020-2031)

9.2 Latin America Manufacturing Execution Systems for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025)

9.4 Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size (2020-2031)

10.2 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025)

10.4 Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Manufacturing Execution Systems for Pharma and Biotech Introduction

11.1.4 Lonza Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.1.5 Lonza Recent Development

11.2 Vimachem

11.2.1 Vimachem Company Details

11.2.2 Vimachem Business Overview

11.2.3 Vimachem Manufacturing Execution Systems for Pharma and Biotech Introduction

11.2.4 Vimachem Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.2.5 Vimachem Recent Development

11.3 Korber

11.3.1 Korber Company Details

11.3.2 Korber Business Overview

11.3.3 Korber Manufacturing Execution Systems for Pharma and Biotech Introduction

11.3.4 Korber Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.3.5 Korber Recent Development

11.4 MasterControl

11.4.1 MasterControl Company Details

11.4.2 MasterControl Business Overview

11.4.3 MasterControl Manufacturing Execution Systems for Pharma and Biotech Introduction

11.4.4 MasterControl Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.4.5 MasterControl Recent Development

11.5 POMS Corporation

11.5.1 POMS Corporation Company Details

11.5.2 POMS Corporation Business Overview

11.5.3 POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Introduction

11.5.4 POMS Corporation Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.5.5 POMS Corporation Recent Development

11.6 AspenTech

11.6.1 AspenTech Company Details

11.6.2 AspenTech Business Overview

11.6.3 AspenTech Manufacturing Execution Systems for Pharma and Biotech Introduction

11.6.4 AspenTech Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.6.5 AspenTech Recent Development

11.7 GE Vernova

11.7.1 GE Vernova Company Details

11.7.2 GE Vernova Business Overview

11.7.3 GE Vernova Manufacturing Execution Systems for Pharma and Biotech Introduction

11.7.4 GE Vernova Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.7.5 GE Vernova Recent Development

11.8 凯睿德

11.8.1 凯睿德 Company Details

11.8.2 凯睿德 Business Overview

11.8.3 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Introduction

11.8.4 凯睿德 Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.8.5 凯睿德 Recent Development

11.9 Dassault Systemes

11.9.1 Dassault Systemes Company Details

11.9.2 Dassault Systemes Business Overview

11.9.3 Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Introduction

11.9.4 Dassault Systemes Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.9.5 Dassault Systemes Recent Development

11.10 IBM

11.10.1 IBM Company Details

11.10.2 IBM Business Overview

11.10.3 IBM Manufacturing Execution Systems for Pharma and Biotech Introduction

11.10.4 IBM Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.10.5 IBM Recent Development

11.11 Rockwell Automation

11.11.1 Rockwell Automation Company Details

11.11.2 Rockwell Automation Business Overview

11.11.3 Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Introduction

11.11.4 Rockwell Automation Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.11.5 Rockwell Automation Recent Development

11.12 ABB

11.12.1 ABB Company Details

11.12.2 ABB Business Overview

11.12.3 ABB Manufacturing Execution Systems for Pharma and Biotech Introduction

11.12.4 ABB Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.12.5 ABB Recent Development

11.13 Accevo Systems

11.13.1 Accevo Systems Company Details

11.13.2 Accevo Systems Business Overview

11.13.3 Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Introduction

11.13.4 Accevo Systems Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.13.5 Accevo Systems Recent Development

11.14 AmpleLogic

11.14.1 AmpleLogic Company Details

11.14.2 AmpleLogic Business Overview

11.14.3 AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Introduction

11.14.4 AmpleLogic Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.14.5 AmpleLogic Recent Development

11.15 Siemens Software

11.15.1 Siemens Software Company Details

11.15.2 Siemens Software Business Overview

11.15.3 Siemens Software Manufacturing Execution Systems for Pharma and Biotech Introduction

11.15.4 Siemens Software Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.15.5 Siemens Software Recent Development

11.16 NNIT

11.16.1 NNIT Company Details

11.16.2 NNIT Business Overview

11.16.3 NNIT Manufacturing Execution Systems for Pharma and Biotech Introduction

11.16.4 NNIT Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.16.5 NNIT Recent Development

11.17 Metronik

11.17.1 Metronik Company Details

11.17.2 Metronik Business Overview

11.17.3 Metronik Manufacturing Execution Systems for Pharma and Biotech Introduction

11.17.4 Metronik Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.17.5 Metronik Recent Development

11.18 Tulip

11.18.1 Tulip Company Details

11.18.2 Tulip Business Overview

11.18.3 Tulip Manufacturing Execution Systems for Pharma and Biotech Introduction

11.18.4 Tulip Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

11.18.5 Tulip Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cloud-based

Table 3. Key Players of On-premises

Table 4. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Class (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of Electronic Batch Records (EBR)

Table 6. Key Players of Lot Genealogy and Traceability

Table 7. Key Players of Equipment and Material Management

Table 8. Key Players of Quality Management Integration

Table 9. Key Players of Regulatory Compliance

Table 10. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Group (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of Direct Sales

Table 12. Key Players of Distribution

Table 13. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 14. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2020-2025) & (US$ Million)

Table 16. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2020-2025)

Table 17. Global Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 18. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2026-2031)

Table 19. Manufacturing Execution Systems for Pharma and Biotech Market Trends

Table 20. Manufacturing Execution Systems for Pharma and Biotech Market Drivers

Table 21. Manufacturing Execution Systems for Pharma and Biotech Market Challenges

Table 22. Manufacturing Execution Systems for Pharma and Biotech Market Restraints

Table 23. Global Manufacturing Execution Systems for Pharma and Biotech Revenue by Players (2020-2025) & (US$ Million)

Table 24. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Players (2020-2025)

Table 25. Global Top Manufacturing Execution Systems for Pharma and Biotech Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Manufacturing Execution Systems for Pharma and Biotech as of 2024)

Table 26. Ranking of Global Top Manufacturing Execution Systems for Pharma and Biotech Companies by Revenue (US$ Million) in 2024

Table 27. Global 5 Largest Players Market Share by Manufacturing Execution Systems for Pharma and Biotech Revenue (CR5 and HHI) & (2020-2025)

Table 28. Global Key Players of Manufacturing Execution Systems for Pharma and Biotech, Headquarters and Area Served

Table 29. Global Key Players of Manufacturing Execution Systems for Pharma and Biotech, Product and Application

Table 30. Global Key Players of Manufacturing Execution Systems for Pharma and Biotech, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Type (2020-2025) & (US$ Million)

Table 33. Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Type (2020-2025)

Table 34. Global Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 35. Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Type (2026-2031)

Table 36. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Application (2020-2025) & (US$ Million)

Table 37. Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Application (2020-2025)

Table 38. Global Manufacturing Execution Systems for Pharma and Biotech Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 39. Global Manufacturing Execution Systems for Pharma and Biotech Revenue Market Share by Application (2026-2031)

Table 40. North America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)

Table 42. North America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)

Table 43. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)

Table 45. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)

Table 46. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 47. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2020-2025) & (US$ Million)

Table 48. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size by Region (2026-2031) & (US$ Million)

Table 49. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 50. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)

Table 51. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)

Table 52. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2020-2025) & (US$ Million)

Table 54. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size by Country (2026-2031) & (US$ Million)

Table 55. Lonza Company Details

Table 56. Lonza Business Overview

Table 57. Lonza Manufacturing Execution Systems for Pharma and Biotech Product

Table 58. Lonza Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 59. Lonza Recent Development

Table 60. Vimachem Company Details

Table 61. Vimachem Business Overview

Table 62. Vimachem Manufacturing Execution Systems for Pharma and Biotech Product

Table 63. Vimachem Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 64. Vimachem Recent Development

Table 65. Korber Company Details

Table 66. Korber Business Overview

Table 67. Korber Manufacturing Execution Systems for Pharma and Biotech Product

Table 68. Korber Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 69. Korber Recent Development

Table 70. MasterControl Company Details

Table 71. MasterControl Business Overview

Table 72. MasterControl Manufacturing Execution Systems for Pharma and Biotech Product

Table 73. MasterControl Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 74. MasterControl Recent Development

Table 75. POMS Corporation Company Details

Table 76. POMS Corporation Business Overview

Table 77. POMS Corporation Manufacturing Execution Systems for Pharma and Biotech Product

Table 78. POMS Corporation Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 79. POMS Corporation Recent Development

Table 80. AspenTech Company Details

Table 81. AspenTech Business Overview

Table 82. AspenTech Manufacturing Execution Systems for Pharma and Biotech Product

Table 83. AspenTech Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 84. AspenTech Recent Development

Table 85. GE Vernova Company Details

Table 86. GE Vernova Business Overview

Table 87. GE Vernova Manufacturing Execution Systems for Pharma and Biotech Product

Table 88. GE Vernova Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 89. GE Vernova Recent Development

Table 90. 凯睿德 Company Details

Table 91. 凯睿德 Business Overview

Table 92. 凯睿德 Manufacturing Execution Systems for Pharma and Biotech Product

Table 93. 凯睿德 Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 94. 凯睿德 Recent Development

Table 95. Dassault Systemes Company Details

Table 96. Dassault Systemes Business Overview

Table 97. Dassault Systemes Manufacturing Execution Systems for Pharma and Biotech Product

Table 98. Dassault Systemes Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 99. Dassault Systemes Recent Development

Table 100. IBM Company Details

Table 101. IBM Business Overview

Table 102. IBM Manufacturing Execution Systems for Pharma and Biotech Product

Table 103. IBM Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 104. IBM Recent Development

Table 105. Rockwell Automation Company Details

Table 106. Rockwell Automation Business Overview

Table 107. Rockwell Automation Manufacturing Execution Systems for Pharma and Biotech Product

Table 108. Rockwell Automation Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 109. Rockwell Automation Recent Development

Table 110. ABB Company Details

Table 111. ABB Business Overview

Table 112. ABB Manufacturing Execution Systems for Pharma and Biotech Product

Table 113. ABB Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 114. ABB Recent Development

Table 115. Accevo Systems Company Details

Table 116. Accevo Systems Business Overview

Table 117. Accevo Systems Manufacturing Execution Systems for Pharma and Biotech Product

Table 118. Accevo Systems Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 119. Accevo Systems Recent Development

Table 120. AmpleLogic Company Details

Table 121. AmpleLogic Business Overview

Table 122. AmpleLogic Manufacturing Execution Systems for Pharma and Biotech Product

Table 123. AmpleLogic Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 124. AmpleLogic Recent Development

Table 125. Siemens Software Company Details

Table 126. Siemens Software Business Overview

Table 127. Siemens Software Manufacturing Execution Systems for Pharma and Biotech Product

Table 128. Siemens Software Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 129. Siemens Software Recent Development

Table 130. NNIT Company Details

Table 131. NNIT Business Overview

Table 132. NNIT Manufacturing Execution Systems for Pharma and Biotech Product

Table 133. NNIT Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 134. NNIT Recent Development

Table 135. Metronik Company Details

Table 136. Metronik Business Overview

Table 137. Metronik Manufacturing Execution Systems for Pharma and Biotech Product

Table 138. Metronik Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 139. Metronik Recent Development

Table 140. Tulip Company Details

Table 141. Tulip Business Overview

Table 142. Tulip Manufacturing Execution Systems for Pharma and Biotech Product

Table 143. Tulip Revenue in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025) & (US$ Million)

Table 144. Tulip Recent Development

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

Table 148. Authors List of This Report

List of Figures

Figure 1. Manufacturing Execution Systems for Pharma and Biotech Picture

Figure 2. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Type: 2024 VS 2031

Figure 4. Cloud-based Features

Figure 5. On-premises Features

Figure 6. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Comparison by Class (2020-2031) & (US$ Million)

Figure 7. Electronic Batch Records (EBR) Features

Figure 8. Lot Genealogy and Traceability Features

Figure 9. Equipment and Material Management Features

Figure 10. Quality Management Integration Features

Figure 11. Regulatory Compliance Features

Figure 12. Global Manufacturing Execution Systems for Pharma and Biotech Market Size Comparison by Group (2020-2031) & (US$ Million)

Figure 13. Direct Sales Features

Figure 14. Distribution Features

Figure 15. Global Manufacturing Execution Systems for Pharma and Biotech Market Size by Application (2020-2031) & (US$ Million)

Figure 16. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Application: 2024 VS 2031

Figure 17. Large Enterprises Case Studies

Figure 18. SMEs Case Studies

Figure 19. Manufacturing Execution Systems for Pharma and Biotech Report Years Considered

Figure 20. Global Manufacturing Execution Systems for Pharma and Biotech Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Manufacturing Execution Systems for Pharma and Biotech Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Region: 2024 VS 2031

Figure 23. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Players in 2024

Figure 24. Global Manufacturing Execution Systems for Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. The Top 10 and 5 Players Market Share by Manufacturing Execution Systems for Pharma and Biotech Revenue in 2024

Figure 26. North America Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2020-2031)

Figure 28. United States Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2020-2031)

Figure 32. Germany Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Ireland Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Manufacturing Execution Systems for Pharma and Biotech Market Share by Region (2020-2031)

Figure 40. China Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia & New Zealand Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2020-2031)

Figure 48. Mexico Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Manufacturing Execution Systems for Pharma and Biotech Market Share by Country (2020-2031)

Figure 52. Israel Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Manufacturing Execution Systems for Pharma and Biotech Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Lonza Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 56. Vimachem Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 57. Korber Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 58. MasterControl Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 59. POMS Corporation Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 60. AspenTech Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 61. GE Vernova Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 62. 凯睿德 Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 63. Dassault Systemes Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 64. IBM Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 65. Rockwell Automation Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 66. ABB Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 67. Accevo Systems Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 68. AmpleLogic Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 69. Siemens Software Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 70. NNIT Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 71. Metronik Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 72. Tulip Revenue Growth Rate in Manufacturing Execution Systems for Pharma and Biotech Business (2020-2025)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions